1.SGLT2i as fourth-line therapy and risk of mortality, end-stage renal diseases and cardiovascular diseases in patients with type 2 diabetes mellitus
Wong, CKH, Tang, EHM
More...
Wong, CKH, Tang, EHM, Man, KKC, Chan, EWY, Wong, ICK, Lam, CLK
Less
DIABETES & METABOLISM[1262-3636],
Published 2021,
Volume 47,
Issue 4,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 8
2023影響因子:
4.6
发表年影響因子:
8.254